Forward Looking Statements
Some of the information in this section contains forward-looking statements that
involve substantial risks and uncertainties. You can identify these statements
by forward-looking words such as "may," "will," "expect," "anticipate,"
"believe," "estimate" and "continue," or similar words.
We believe it is important to communicate our expectations. However, there may
be events in the future that we are not able to accurately predict or over which
we have no control. Our actual results and the timing of certain events could
differ materially from those anticipated in these forward-looking statements as
a result of certain factors, including those set forth elsewhere in this
Quarterly Report on Form 10-Q.
Unless stated otherwise, the words "we," "us," "our," "the Company" or
"Innovative MedTech" in this Quarterly Report on Form 10-Q collectively refers
to Innovative MedTech, Inc., a Delaware corporation (the "Parent Company"), and
subsidiaries.
Overview
Innovative MedTech, Inc. (the "Company"), a Delaware corporation, is a provider
of health and wellness services. On March 25, 2021, the Company acquired
SarahCare for a total of $3,718,833; $2,000,110 was paid in cash and the Company
assumed approximately $393,885 in debt due to sellers, and the remaining is
payable through a royalty fee liability due in the amount of $1,500,000. With 26
centers (2 corporate and 24 franchise locations) located in 13 states, SarahCare
offers seniors daytime care and activities focusing on meeting their physical
and medical needs on a daily basis, and ranging from nursing care to salon
services and providing meals, to offering engaging and enriching activities to
allow them to continue to lead active and engaged lives.
The Company has also been working on launching an RX Vitality wallet digital
offering and mobile app. Once implemented and live, the Company's digital
healthcare wallet will be accessible by customers via mobile wallet on both the
Apple iOS and Android App Stores. The Company intends to have a physical
healthcare card as well.
On April 1, 2022, the Company partnered with TruCash Group of Companies Inc.
("TruCash"), a leading global payments provider, to launch an all-in-one Super
Healthcare App, called RX Vitality Wallet, that will be designed to cater to
consumers, patients, hospitals, Seniors, and governments, with a solid platform
of benefits and online banking. The RX Vitality digital healthcare wallet is
being designed to offer 20%-75% pharmaceutical discounts at 65,000 pharmacies
across the United States, including Walgreens and CVS. In addition, we plan to
offer health and wellness discounts at 500+ online merchants, as well as earning
points on our Loyalty Program. The Company intends to generate revenue from its
digital wallet and mobile app in multiple ways, including but not limited to
monthly recurring fees, transfer fees, and the inter-exchange rate. On June 15,
2022, the Company's RX Vitality digital healthcare wallet became available for
download at the Apple iOS App store for Apple iPhone users. The Company's app
has also been approved and is available on the Google Play Store.
On April 5, 2022, the Company engaged mPulse Mobile, a leader in conversational
AI and digital engagement solutions for the healthcare industry, to drive
engagement with the Company's digital app and wallet (currently under
development).
On April 28, 2022, the Company entered into a share exchange agreement to
acquire RX Vitality, Inc. ("RX Vitality"), a media and finance advisory company.
On May 13, 2022, the Company entered into a partnership with VSUSA Corp.
("VSUSA"), a non-for-profit organization that empowers Veterans and Seniors by
offering services designed to build successful life transitions with access to
workforce and independent housing; health services; and social service programs
in communities across the United States. The partnership will permit the Company
to use the VSUSA logo on the back of its Vitality Debit Card. For this the
Company will give up to 1% of its revenue generated from its Vitality Debit Card
to VSUSA. The Company's Chairman is a principal and co-Founder of VSUSA.
As of September 30, 2022, the Company had current assets of $359,388. The
Company has a limited amount of liquid cash and no other liquid assets on hand
as of September 30, 2022, and this is not sufficient to fund operations for the
next 12 months. Accordingly, we will be required to raise additional funds to
meet our short and long-term planned goals. There can be no assurance that such
funds, if available at all, can be obtained on terms reasonable to us. In this
regard, we have obtained and will continue to attempt to obtain (short and long
term) loans for inventory purchases, new product development, expansion,
advertising and marketing. We cannot assure you that we will be successful in
obtaining the aforementioned financings (either debt or equity) on terms
acceptable to us, or otherwise.
Our unaudited consolidated financial statements contained in this Quarterly
Report on Form 10-Q have been prepared on a going concern basis, which assumes
that we will be able to realize our assets and discharge our obligations in the
normal course of business.
28
Results of Operations for the Three Months Ended September 30, 2022, and
September 30, 2021
For the quarter ended September 30, 2022, we recorded gross revenues of $384,150
versus $316,566 for the quarter ended September 30, 2021, as a result of the
Company's ability to keep centers open for longer periods of time, and more
participants coming to the center more often.
For the quarter ended September 30, 2022, operating expenses increased to
$1,347,158 from $614,723, a $732,435 increase, or 119.51%, over the quarter
ended September 30, 2021. The increase is due to an increase in expenses due to
the Company's acquisition of RX Vitality and the initiating the development of
its RX Vitality Wallet and debit card.
For the quarter ended September 30, 2022, interest expense on our convertible
notes payable decreased to $9,747 from $26,313, a decrease of 62.96% over the
quarter ended September 30, 2021. This decrease is primarily due to an decrease
in interest expense.
For the quarter ended September 30, 2022, we realized a net loss of $1,000,490
as compared to a net loss of $259,318 for the quarter ended September 30, 2021.
The increase in our net loss of $741,172 was primarily due to an increase in
licensing expenses due to the Company's acquisition of RX Vitality and the
initiating the development of its RX Vitality Wallet and debit card.
Liquidity and Capital Resources
Based upon our current financial condition, we do not have sufficient cash to
operate our business at the current level for the next twelve months. We intend
to fund operations through debt and/or equity financing arrangements, which may
be insufficient to fund expenditures or other cash requirements. We plan to seek
additional financing in a private equity offering to secure funding for
operations. There can be no assurance that we will be successful in raising
additional funding. If we are not able to secure additional funding, the
implementation of our business plan will be impaired. There can be no assurance
that such additional financing will be available to us on acceptable terms or at
all.
Off Balance Sheet Arrangements
We currently have no off-balance sheet arrangements that have or are reasonably
likely to have a current or future material effect on our financial condition,
changes in financial condition, revenues or expenses, results of operations,
liquidity, capital expenditures or capital resources.
Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires us to make a number
of estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements. Such estimates and assumptions affect the reported
amounts of revenues and expenses during the reporting period. We base our
estimates on historical experiences and on various other assumptions that we
believe to be reasonable under the circumstances. Actual results may differ
materially from these estimates under different assumptions and conditions. We
continue to monitor significant estimates made during the preparation of our
financial statements. On an ongoing basis, we evaluate estimates and assumptions
based upon historical experience and various other factors and circumstances. We
believe our estimates and assumptions are reasonable in the circumstances;
however, actual results may differ from these estimates under different future
conditions.
Inflation
We do not believe that inflation had a significant impact on our results of
operations for the periods presented.
29
© Edgar Online, source Glimpses